Arcturus Bioscience Overview
- Founded
-
1996
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Arcturus Bioscience General Information
Description
Developer of technology platform for genetic analysis of biopsy samples to discover cell-specific gene signatures. The company develops laser capture microdissection (LCM) instruments and reagents for the analysis of microscopic tissue samples, with systems installed in cancer centers and other research and clinical laboratories worldwide.
Contact Information
Primary Office
- 400 Logue Avenue
- Mountain View, CA 94043
- United States
Arcturus Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 01-Apr-2006 | 000.00 | Completed | Generating Revenue | ||
| 2. Bridge | 28-Nov-2005 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 1. Later Stage VC (Series G) | 01-Apr-2004 | $16.4M | $16.4M | Completed | Generating Revenue |
Arcturus Bioscience Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| ABS Capital Partners | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
| DynaFund Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Summit Partners | PE/Buyout | Minority | 000 0000 | 000000 0 |